BioSpace News Archive

Business

Vaccinex Reports First Quarter 2022 Results and Provides Corporate Update

Vaccinex Reports First Quarter 2022 Results and Provides Corporate Update.

May 16, 2022
·
14 min read
Innovative AI software for the detection of pancreatic diseases: first-in-human application successful

Diseases of the pancreas can have serious consequences for patients and are difficult to diagnose.

May 16, 2022
·
2 min read
Business

Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer treatment, today announced the appointment of Steve Sabus as Chief Commercial Officer, effective as of May 31, 2022.

May 16, 2022
·
4 min read
BioMidwest

POINT Biopharma Unveils FRONTIER: A Pan-Cancer FAP-α Targeted Clinical Program

POINT Biopharma Global Inc. today announced details of the initial clinical trial in the Company’s pan-cancer Fibroblast Activation Protein-α (FAP-α) targeted program PNT2004, FRONTIER.

May 16, 2022
·
6 min read
Ascletis (1672.HK) Included in MSCI China Small Cap Index

Ascletis Pharma Inc. announces that it will be included in the MSCI China Small Cap Index, effective after the market close on May 31, 2022.

May 16, 2022
·
2 min read
BioMidwest

Artivion to Participate in the UBS 2022 Global Healthcare Conference

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it will participate in the upcoming UBS 2022 Global Healthcare Conference on Monday, May 23, 2022 at the Lotte New York Palace.

May 16, 2022
·
1 min read